Markets | | Fertility benefits management company Progyny, Inc. (NASDAQ: PGNY) fills a void in health insurance coverage that the world’s leading companies embrace to attract and keep top talent. Infertility coverage that is not deemed ‘medically necessary’ is not covered by most health plans... Read the Full Story |
|
From Our Partners | | BioStem Technologies (NASDAQ: BSEM) just completed its Nasdaq debut, and hospital revenue already makes up about 87% of first-quarter sales.
The BioTissue acquisition added the Neox and Clarix portfolios and GPO relationships, while the direct sales team grew from 18 to 35 reps in a single quarter.
A peer-reviewed trial found a 53% complete wound closure rate with BioREtain allografts versus 31% for standard care, backing coverage from Zacks Small-Cap Research and H.C. Wainwright. | | Discover how BSEM is building out its regenerative medicine platform |
|
Markets | |
It's been amazing to witness the way that technology has changed how businesses operate over the last decade. With new data storage capabilities that can dramatically improve the efficiency of how companies function, most businesses are quickly making the move to the cloud. Major corporations are ... Read the Full Story |
|
Markets | |
Finding good stocks to buy in the market these days is no easy task. Although stocks have rebounded nicely off of the March lows, many investors are having trouble figuring out why. Some even believe that we have never seen such a large disconnect between equity valuations and fundamentals. Even b... Read the Full Story |
|
From Our Partners | | A 20-minute read could change how you approach your next options trade. Chris Pulver is giving away his guide, Right About The Market, Wrong About The Money, free of charge.
Built from two decades of trading experience, the guide tackles a common problem: losing a trade even when your market call was correct.
No cost, no catch, just a packed resource for options traders who want a sharper edge. | | Click here to get your free copy of the guide |
|
Markets | |
Latin America is a region of the world that seems to be a little late to the party in terms of adapting e-commerce into their everyday life. However, that seems to be changing fast thanks to MercadoLibre (NASDAQ:MELI), which is a rapidly growing online commerce and payments business. The company r... Read the Full Story |
|
Markets | |
On Friday, May 8 Kimco Realty (NYSE:KIM) posted a positive first-quarter earnings report. For a real estate investment trust (REIT), the quarterly funds from operation (FFO) is a critical metric. And Kimco delivered FFO of 37 cents per share. This beat analysts’ estimates for 36 cents per sh... Read the Full Story |
|
From Our Partners | | Unitree's IPO grabbed headlines, but a handful of already-public robotics companies have been quietly delivering results that look nothing like hype.
One robotics-and-testing firm grew quarterly revenue from $686 million to $1.282 billion year over year and broke out above a $422.11 buy point. A warehouse robotics company exited the quarter with a $22.7 billion backlog and $2.0 billion in cash with no debt. A robotic surgery leader placed 431 systems in a single quarter. | | Get the free robotics stock report now. |
|
Markets | |
As volatile as the stock market has been for the last couple of months now, the cryptocurrency market has been that volatile for years now. Bitcoin, pretty much the gold standard in cryptocurrency, has seen wild changes in valuation just in the last year. The price over the last year retested the ... Read the Full Story |
|
Markets | | Clorox Is The #1 Bet For Pandemic-Driven Gains
Clorox (CLX) reported earnings for the first quarter last week and gave what I called then a “goldilocks report”. The headline figures were above consensus, they showed growth from the previous year, and were backed up by internal data that... Read the Full Story |
|
Markets | | Despite their shares taking a heavy beating with the rest of the equity market in March, over the past few weeks Peloton (NASDAQ: PTON) has joined the ranks of stocks that ended up hitting fresh all time highs in the face of the coronavirus pandemic. In light of many non-essential businesses shuttin... Read the Full Story |
|
Technology | |
In recent years, watching Apple (NASDAQ: AAPL) acquire company after company has been something of a pastime for the tech field. Between that and watching what comes out of the Apple patent mill, it's been a great way to get a better idea of where the company's going and what it might be planning... Read the Full Story |
|
Markets | | Consumer Staples, It’s What You Want To Own
The consumer staples (XLP) stocks have been on a tear and no wonder. The global coronavirus pandemic is driving people to stay home, stock up, and social-distance, and that means big spending in the staples categories. Companies like Conagra (CAG), ... Read the Full Story |
|
The Early Bird Stock Of The Day Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California. | | View Today's Stock Pick |
|
